Industry News
Researchers find clue to cancer cell survival
Groundbreaking protein and cell biology research has discovered a new way to alter the survival of cancer cells by targeting active sarcoma kinase signalling.
[ + ]Urgent boost needed for science and maths
The Australian Academy of Science urged the Federal Government to increase its efforts to attract and retain university students in science and mathematics.
[ + ]New discovery of stem cells gives hope for heart regeneration
Sydney researchers have discovered a new population of adult stem cells in the heart which could augment the development of new regeneration and repair therapies for people who have suffered heart attack or heart failure - the leading cause of death in Australia.
[ + ]Manufacturing taskforce an opportunity for life science sector
AusBiotech will be lobbying for a greater emphasis on biopharma and medical devices on the newly established Prime Minister's Taskforce on Manufacturing. [ + ]
Victorian Government establishes Biotechnology Advisory Council
Biotechnology Advisory Council will advise the government on current and emerging opportunities and threats to the biotechnology sector and aid in implementation of policy. [ + ]
Fluorospectrometer to improve GFR measurements in mice
The UC Division of Nephrology/Hypertension has used a fluorospectrometer to detect GFR in mice.
[ + ]AstraZeneca invests in Victoria's NeuProtect
Victorian biopharma NeuProtect has added AstraZeneca's venture capital subsidiary, MedImmune Ventures, as a new investor. [ + ]
AusBiotech CEO appointed to Research Australia Board
AusBiotech CEO, Dr Anna Lavelle, has been appointed to the Board of Research Australia, effective from the annual general meeting held recently. [ + ]
Diabetes: one size doesn’t fit all
The Garvan's Professor David James challenges many assumptions about diabetes, its causes and treatments, including whether obesity is always a bad thing. [ + ]
Immuron signs distribution deal worth up to $113 million
Immuron (ASX:IMC) has secured a multi-market distribution deal worth up to C$115.5 million ($112.7m) for its debut OTC antibody product, Travelan. [ + ]
Clinical trials data sought for first-of-kind study
The Federal Government is conducting a first-of-its-kind study to gauge the level of privately funded clinical research activity in Australia. [ + ]
iSonea ramps up product efforts
Acoustic respiratory monitoring company iSonea (ASX:ISN) will use funds from a $4.3 million capital raising to expedite the search for a distribution partner. [ + ]
Stem cells undergo evolution in the lab
A new study has found cultured human embryonic stem cells undergo selection for greater self-renewal, which has implications on stem cell therapies. [ + ]
Organovo wins innovation award for 3D bioprinter
Start-up Organovo and partner Inventech have won this year's AusIndustry-sponsored Engineering Innovation Award for their 3D bioprinter product. [ + ]
Feature: Beyond the hype of algal biofuels
Algal biofuels have been much hyped, but the reality is getting closer every day. Chemical engineer and algal biofuels researcher David Lewis brings algae down to earth. [ + ]